Anna Beatriz Oliveira Cruz

Mrs. Anna Beatriz Oliveira Cruz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
MVMax Denisson Maurício Viana
Max Denisson Maurício Viana
SSSthefane Silva Santos
Sthefane Silva Santos
ACAnna Beatriz Oliveira Cruz
Anna Beatriz Oliveira Cruz
MJMaria Vitória Abreu Cardoso de Jesus
Maria Vitória Abreu Cardoso de Jesus
PLPedro Santana Sales Lauria
Pedro Santana Sales Lauria
Cristiane Flora VillarrealCristiane Flora Villarreal
Cristiane Flora Villarreal
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by impaired glycemic regulation and persistent hyperglycemia, which drives the onset of microvascular complications such as diabetic neuropathy and nephropathy. Chronic hyperglycemia activates oxidative stress pathways and alters gut microbiota composition, both of which contribute to disease progression. In this context, probiotics have emerged as promising therapeutic agents due to their ability to modulate oxidative stress, improve glycemic control, and influence gut microbial balance. This review summarizes preclinical and clinical evidence supporting the antioxidant potential of probiotics in DM management, with a focus on underlying mechanisms. Strains from the Lactobacillus and Bifidobacterium genera are the most extensively studied and have demonstrated hypoglycemic and antioxidant effects, including the enhancement of key antioxidant enzymes and reductions in lipid peroxidation and nitrosative stress markers. Probiotics have also shown beneficial effects in DM-associated complications, particularly diabetic neuropathy and nephropathy. While clinical data are still limited, recent findings underscore oxidative stress as a critical therapeutic target influenced by probiotic interventions. Overall, current evidence supports probiotics as a complementary strategy for managing DM and its complications, highlighting the need for further well-designed clinical trials exploring diverse strains, formulations, and dosing regimens.

23 May 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GSGabriel Carvalho de Souza Santana
Gabriel Carvalho de Souza Santana
MJMaria Vitória Abreu Cardoso de Jesus
Maria Vitória Abreu Cardoso de Jesus
ACAnna Beatriz Oliveira Cruz
Anna Beatriz Oliveira Cruz
ALAlyne Almeida de Lima
Alyne Almeida de Lima
PLPedro Santana Sales Lauria
Pedro Santana Sales Lauria
Cristiane Flora VillarrealCristiane Flora Villarreal
Cristiane Flora Villarreal